BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19745653)

  • 1. Atypical neuroleptic malignant syndrome with quetiapine: a case report and review of the literature.
    El-Gaaly S; St John P; Dunsmore S; Bolton JM
    J Clin Psychopharmacol; 2009 Oct; 29(5):497-9. PubMed ID: 19745653
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroleptic malignant syndrome secondary to quetiapine.
    Gortney JS; Fagan A; Kissack JC
    Ann Pharmacother; 2009 Apr; 43(4):785-91. PubMed ID: 19299325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quetiapine-induced neuroleptic malignant syndrome in dementia with Lewy bodies: a case report.
    Kobayashi A; Kawanishi C; Matsumura T; Kato D; Furukawa R; Kishida I; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1170-2. PubMed ID: 16682107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome induced by quetiapine and fluvoxamine.
    Matsumoto R; Kitabayashi Y; Nakatomi Y; Tsuchida H; Fukui K
    Am J Psychiatry; 2005 Apr; 162(4):812. PubMed ID: 15800166
    [No Abstract]   [Full Text] [Related]  

  • 5. Intolerable fever: a previously unreported side-effect of quetiapine.
    Gutman S; Layland J
    Aust N Z J Psychiatry; 2012 Jan; 46(1):72-3. PubMed ID: 22247102
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuroleptic malignant syndrome associated with quetiapine.
    al-Waneen R
    Can J Psychiatry; 2000 Oct; 45(8):764-5. PubMed ID: 11086565
    [No Abstract]   [Full Text] [Related]  

  • 7. [Priapism associated with quetiapine in an elderly patient].
    Andrés Prado MJ; Vidal Formoso M
    Actas Esp Psiquiatr; 2006; 34(3):209-10. PubMed ID: 16736396
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypothyroidism induced by quetiapine: a case report.
    Liappas J; Paparrigopoulos T; Mourikis I; Soldatos C
    J Clin Psychopharmacol; 2006 Apr; 26(2):208-9. PubMed ID: 16633154
    [No Abstract]   [Full Text] [Related]  

  • 9. Atypical neuroleptic malignant syndrome in an adolescent.
    Rais AR; Kimmel S; Shrestha N; Rais TB; Coffey BJ
    J Child Adolesc Psychopharmacol; 2008 Apr; 18(2):215-20. PubMed ID: 18439120
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome with use of quetiapine in mental retardation.
    Dan A; Bharadwaj R; Grover S
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):255-6. PubMed ID: 19335404
    [No Abstract]   [Full Text] [Related]  

  • 11. Quetiapine and neuroleptic malignant syndrome.
    Solomons K
    Can J Psychiatry; 2002 Oct; 47(8):791. PubMed ID: 12420666
    [No Abstract]   [Full Text] [Related]  

  • 12. [Neuroleptic malignant syndrome].
    Bryois C; Bondolfi G
    Rev Med Suisse Romande; 1996 Sep; 116(9):713-7. PubMed ID: 8966472
    [No Abstract]   [Full Text] [Related]  

  • 13. Extrapontine myelinolysis resembling neuroleptic malignant syndrome.
    Groff KE; Lam C; Caroff SN
    J Clin Psychopharmacol; 2005 Dec; 25(6):620-1. PubMed ID: 16282856
    [No Abstract]   [Full Text] [Related]  

  • 14. Are neuroleptic malignant syndrome and serotonin syndrome the same syndrome?
    Steele D; Keltner NL; McGuiness TM
    Perspect Psychiatr Care; 2011 Jan; 47(1):58-62. PubMed ID: 21418073
    [No Abstract]   [Full Text] [Related]  

  • 15. Failed challenge with quetiapine after neuroleptic malignant syndrome with conventional antipsychotics.
    Hatch CD; Lund BC; Perry PJ
    Pharmacotherapy; 2001 Aug; 21(8):1003-6. PubMed ID: 11718487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of neuroleptic malignant syndrome with quetiapine.
    Bourgeois JA; Babine S; Meyerovich M; Doyle J
    J Neuropsychiatry Clin Neurosci; 2002; 14(1):87. PubMed ID: 11884665
    [No Abstract]   [Full Text] [Related]  

  • 17. Quetiapine and clarithromycin-induced neuroleptic malignant syndrome.
    Christodoulou C; Margaritis D; Makris G; Kavatha D; Efstathiou V; Papageorgiou C; Douzenis A
    Clin Neuropharmacol; 2015; 38(1):36-7. PubMed ID: 25580921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptic malignant-like syndrome induced with low-dose quetiapine treated with electroconvulsive therapy.
    Bora E; Saffet Gonul A; Akdeniz F; Vahip S
    Eur Psychiatry; 2003 Oct; 18(6):323. PubMed ID: 14611931
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinico-therapeutic observations in the neuroleptic malignant syndrome].
    Grecu G; Grecu-Gaboş M; Nireşteanu A; Grecu-Gaboş I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1989; 34(4):267-76. PubMed ID: 2577227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials.
    McIntyre RS; Muzina DJ; Adams A; Lourenco MT; Law CW; Soczynska JK; Woldeyohannes HO; Nathanson J; Kennedy SH
    Expert Opin Pharmacother; 2009 Dec; 10(18):3061-75. PubMed ID: 19954275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.